Skip to content

Electro-acupuncture to Treat Disorder of Consciousness

Electro-acupuncture to Treat Disorder of Consciousness

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06268236
Enrollment
50
Registered
2024-02-20
Start date
2024-01-01
Completion date
2026-01-31
Last updated
2024-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Disorder of Consciousness, Electroacupuncture

Keywords

Acute brain injury, Disorder of consciousness, Electro-acupuncture, Awakening, Brain functional network

Brief summary

With the rapid development of life support technology, more and more people can survive severe brain injury. Some survivors regain consciousness after a period of coma, however, many patients develop prolonged disorders of consciousness (DOC), which poses a therapeutic challenge for clinicians and a heavy burden for their families. The investigators design an Electro-acupuncture to treat disorder of consciousness (AcuDoc) trial with the aim of validating the clinical effect of electroacupuncture in treating DOC and exploring its therapeutic mechanisms by integrating EEG, neuroimaging, evoked potential tests, and behavioral assessments.

Detailed description

The AcuDoc trial is a single-center, prospective, triple masking, randomized, sham electroacupuncture-controlled study. A total of 50 adult patients with DOC and 25 healthy subjects will be enrolled in the study . Patients will be randomized into electroacupuncture (EA) group or sham EA group (1:1). All patients will receive EA or sham-EA treatment in the supine position at 9 am for 30 minutes once a day for consecutive 14 days and healthy subjects will receive no treatments. The primary objective is to determine the therapeutic benefit of electroacupuncture on the recovery of consciousness in patients with DOC after a 2-week intervention. Key secondary objective is to investigate the effect of electroacupuncture on the circuitry of consciousness using a multimodal approach integrating EEG, neuroimaging (rs-fMRI, amide proton transfer imaging, intravoxel incoherent motion imaging, neurite orientation dispersion and density imaging), and evoked potentials (SEP, BAEP). Other secondary outcomes include the effect of EA on the assessment of brain-computer interface after a 2-week intervention and on the Glasgow Outcome Scale-Extended score at 30 days and 90 days .

Interventions

OTHERElectroacupuncture

Electro-acupuncture at Shuigou and Yintang.

OTHERSham electroacupuncture

Sham-EA at sham-Shuigou and sham-Yintang.

Sponsors

The Second Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. Age ≥ 18 years; 2. With cerebral damage due to TBI; 3. Diagnosed with UWS or MCS based on at least two CRS-R assessments; 4. From 4 to 16 weeks from the onset of brain injury; 5. Informed consent obtained.

Exclusion criteria

1. With a history of neurological or psychiatric disorder prior to the brain injury; 2. With uncontrolled seizures or status epilepticus; 3. Unstable vital signs and requiring the use of vasoactive agents; 4. With the use of general anesthetics or central acting sedative; 5. Without intact skin at acupoints or sham points; 6. Concomitant medical illness that would interfere with the outcome assessments and/or follow-up 7. Pregnant patients; 8. Currently participating in other investigational trials; 9. High likelihood of not adhering to the study treatment or the follow-up regimen

Design outcomes

Primary

MeasureTime frameDescription
Coma Recovery Scale - Revised scoreafter 14 days of EA or sham-EA treatment0 - 23, a higher score indicates a better level of consciousness

Secondary

MeasureTime frameDescription
phase locking valueafter 14 days of EA or sham-EA treatmentmeasured by electroencephalogram
amplitude of low-frequency fluctuationafter 14 days of EA or sham-EA treatmentmeasured by resting-state functional magnetic resonance imaging
Amide proton transfer-weighted signalafter 14 days of EA or sham-EA treatmentmeasured by amide proton transfer imaging
f valueafter 14 days of EA or sham-EA treatmentmeasured by intravoxel incoherent motion imaging
brain-computer interface accuracyafter 14 days of EA or sham-EA treatmentmeasured by electroencephalogram-based brain-computer interface experiment
latency value of N20after 14 days of EA or sham-EA treatmentmeasured by somatosensory evoked potential biomarkers
latency between III and V potentialsafter 14 days of EA or sham-EA treatmentmeasured by brainstem auditory evoked potential
Glasgow Outcome Scale-Extended score30 days after randomization1 - 8, a higher score indicates better functional recovery from brain injury
neurite density indexafter 14 days of EA or sham-EA treatmentmeasured by neurite orientation dispersion and density imaging

Countries

China

Contacts

Primary ContactFang Yuan, PhD
yuanfang@gzucm.edu.cn+86-20-81887233
Backup ContactJixiang Chen, PhD
756337176@qq.com

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026